Conditions: Multiple System Atrophy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 174
Healthy volunteers: no

Brief summary:
To test the clinical effect of rasagiline on subjects with MSA of the parkinsonian subtype.

Detailed description:

Arms:
arm 1: rasagiline tablet, 1 mg/day for up to 48 weeks. arm 2: placebo tablet for up to 48 weeks.

Interventions: intervention 1: rasagiline mesylate intervention 2: placebo
Intervention descriptions: intervention 1: rasagiline 1 mg tablet/day for 48 weeks intervention 2: placebo tablet for 48 weeks

Protocol document: